{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:32:42Z","timestamp":1781818362409,"version":"3.54.5"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T00:00:00Z","timestamp":1449532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T00:00:00Z","timestamp":1449532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/gt.2015.110","type":"journal-article","created":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T15:40:35Z","timestamp":1449675635000},"page":"306-312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia"],"prefix":"10.1038","volume":"23","author":[{"given":"M R","family":"Kibbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A T","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F O","family":"Mendelsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Saucedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Marston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W-B","family":"Pyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-K","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B G","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Comerota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Bartow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D W","family":"Losordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Driver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E C","family":"Perin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,8]]},"reference":[{"key":"BFgt2015110_CR1","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/archinte.163.8.884","volume":"163","author":"JJ Belch","year":"2003","unstructured":"Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003; 163: 884\u2013892.","journal-title":"Arch Intern Med"},{"key":"BFgt2015110_CR2","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45: S5\u201367.","journal-title":"J Vasc Surg"},{"key":"BFgt2015110_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1358863X08089277","volume":"13","author":"AT Hirsch","year":"2008","unstructured":"Hirsch AT, Hartman L, Town RJ, Virnig BA . National health care costs of peripheral arterial disease in the Medicare population. Vasc Med 2008; 13: 209\u2013215.","journal-title":"Vasc Med"},{"key":"BFgt2015110_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.0886-0440.2005.200373.x","volume":"20","author":"V Jayasankar","year":"2005","unstructured":"Jayasankar V, Woo YJ, Pirolli TJ, Bish LT, Berry MF, Burdick J et al. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure. J Card Surg 2005; 20: 93\u2013101.","journal-title":"J Card Surg"},{"key":"BFgt2015110_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/oxfordjournals.jbchem.a021283","volume":"119","author":"K Matsumoto","year":"1996","unstructured":"Matsumoto K, Nakamura T . Emerging multipotent aspects of hepatocyte growth factor. J Biochem 1996; 119: 591\u2013600.","journal-title":"J Biochem"},{"key":"BFgt2015110_CR6","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/gt.2010.101","volume":"17","author":"WB Pyun","year":"2010","unstructured":"Pyun WB, Hahn W, Kim DS, Yoo WS, Lee SD, Won JH et al. Naked DNA expressing two isoforms of hepatocyte growth factor induces collateral artery augmentation in a rabbit model of limb ischemia. Gene Ther 2010; 17: 1442\u20131452.","journal-title":"Gene Ther"},{"key":"BFgt2015110_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/jgm.1603","volume":"13","author":"W Hahn","year":"2011","unstructured":"Hahn W, Pyun WB, Kim DS, Yoo WS, Lee SD, Won JH et al. Enhanced cardioprotective effects by coexpression of two isoforms of hepatocyte growth factor from naked plasmid DNA in a rat ischemic heart disease model. J Gene Med 2011; 13: 549\u2013555.","journal-title":"J Gene Med"},{"key":"BFgt2015110_CR8","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/mt.2013.69","volume":"21","author":"S Ajroud-Driss","year":"2013","unstructured":"Ajroud-Driss S, Christiansen M, Allen JA, Kessler JA . Phase 1\/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy. Mol Ther 2013; 21: 1279\u20131286.","journal-title":"Mol Ther"},{"key":"BFgt2015110_CR9","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/gt.2011.21","volume":"18","author":"TD Henry","year":"2011","unstructured":"Henry TD, Hirsch AT, Goldman J, Wang YL, Lips DL, McMillan WD et al. Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study. Gene Ther 2011; 18: 788\u2013794.","journal-title":"Gene Ther"},{"key":"BFgt2015110_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/gt.2012.87","volume":"20","author":"JS Kim","year":"2013","unstructured":"Kim JS, Hwang HY, Cho KR, Park EA, Lee W, Paeng JC et al. Intramyocardial transfer of hepatocyte growth factor as an adjunct to CABG: phase I clinical study. Gene Ther 2013; 20: 717\u2013722.","journal-title":"Gene Ther"},{"key":"BFgt2015110_CR11","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1073\/pnas.91.10.4357","volume":"91","author":"K Kawaida","year":"1994","unstructured":"Kawaida K, Matsumoto K, Shimazu H, Nakamura T . Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA 1994; 91: 4357\u20134361.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2015110_CR12","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1161\/CIRCRESAHA.113.300565","volume":"112","author":"Z Raval","year":"2013","unstructured":"Raval Z, Losordo DW . Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Circ Res 2013; 112: 1288\u20131302.","journal-title":"Circ Res"},{"key":"BFgt2015110_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1161\/CIRCULATIONAHA.107.727347","volume":"118","author":"RJ Powell","year":"2008","unstructured":"Powell RJ, Simons M, Mendelsohn FO, Daniel G, Henry TD, Koga M et al. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation 2008; 118: 58\u201365.","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1038\/gt.2016.9","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,4,7]],"date-time":"2016-04-07T00:00:00Z","timestamp":1459987200000}}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt2015110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2015110","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2015110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:09:23Z","timestamp":1648555763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt2015110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,8]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFgt2015110"],"URL":"https:\/\/doi.org\/10.1038\/gt.2015.110","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/gt.2016.9","asserted-by":"object"}]},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,8]]},"assertion":[{"value":"13 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Warren Sherman receives consulting fees from ViroMed. The remaining authors declare no conflicts of interest. We retain sole responsibility for the data, statistical analysis and manuscript content.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}